医学
化学免疫疗法
危险系数
四分位间距
比例危险模型
人口
弥漫性大B细胞淋巴瘤
内科学
共病
回顾性队列研究
淋巴瘤
美罗华
置信区间
环境卫生
作者
Abi Vijenthira,Lee Mozessohn,Chenthila Nagamuthu,Ning Liu,Danielle Blunt,Shabbir M.H. Alibhai,Anca Prica,Matthew C. Cheung
标识
DOI:10.6004/jnccn.2022.7014
摘要
In a population-based sample of older adult patients with DLBCL receiving front-line curative-intent therapy, half were classified as frail, and their adjusted relative rate of death in the first year after starting treatment was 50% higher than that of nonfrail patients. Frailty seems to be associated with poor treatment tolerance and a higher likelihood of requiring acute hospital-based care.
科研通智能强力驱动
Strongly Powered by AbleSci AI